Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial.

@article{Walton2014MavacoxibAM,
  title={Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial.},
  author={Myles Benjamin Walton and Emily Cowderoy and Brandan G Wustefeld-Janssens and B Duncan X Lascelles and John Fred Innes},
  journal={The Veterinary record},
  year={2014},
  volume={175 11},
  pages={280}
}
NSAIDs are the cornerstone of medical management of canine osteoarthritis (OA). Meloxicam is a daily-administered NSAID widely available in a liquid formulation and manufacturer's summary of product characteristics (SPC) advise that it is given at the lowest effective dose. Mavacoxib is a long-acting NSAID given as a monthly tablet. This study compares these drugs in the management of canine OA. In all, 111 dogs with OA of the elbow, hip or stifle were randomly assigned to receive one of these… CONTINUE READING